This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

Polio

  1. When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
    Published: March 2019
    Type: Article
  2. The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.
    Published: March 2019
    Type: Resource Page
  3. This web page provides technical information, resources, and links relevant to microarray patch (also known as MAPs or microneedle patches) development of high priority vaccine and essential medicines. Includes multisectoral information for the community of microarray patch researchers, manufacturers, stakeholders, and technology developers.
    Published: November 2018
    Type: Resource Page
  4. This fact sheet provides an overview of the novel oral polio vaccine (nOPV) program, a consortium of PATH and partners that are working to advance novel vaccine candidates that will enable complete eradication and minimize the risk of polio making a comeback.
    Published: October 2018
    Type: Resource Page
  5. Widespread vaccination is the surest way to halt vaccine-derived poliovirus outbreaks, a tenacious threat of the pre-eradication era.
    Published: October 2018
    Type: Article
  6. In 2017, 74 cases of type 2 poliovirus were reported in Syria before a swift and massive immunization response was deployed to stop the circulating virus in its tracks.
    Published: June 2018
    Type: Article
  7. PATH delivers statement at the 71st World Health Assembly on the need for increased effort behind polio transition and post-certification.
    Published: May 2018
    Type: Resource Page
  8. PATH and partners deliver a statement at the 142nd World Health Organization Executive Board meetings calling for additional focus on polio transition planning ahead of finalizing the strategic action plan by the World Health Assembly.
    Published: January 2018
    Type: Resource Page
  9. Another affordable vaccine against polio will help close the supply gap and improve accessibility for low-income countries
    Published: December 2017
    Type: Announcement
  10. Published: November 2017
    Type: Article
Load more